Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1.docVIP

  • 5
  • 0
  • 约5.34万字
  • 约 13页
  • 2017-05-07 发布于上海
  • 举报

Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1.doc

Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1

Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1 Xiaobao Fan , Qiannan Zhang , Shuang Li, Yifei Lv, Houqiang Su, Huiping Jiang, Zhiming Hao ? ? * Department of Gastroenterology, the First Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, China Abstract Transforming growth factor β1 (TGF-β1) is the pivotal pro-fibrogenic cytokine in hepatic fibrosis. Reducing the over- produced expression of TGF-β1 or blocking its signaling pathways is considered to be a promising therapeutic strategy for hepatic fibrosis. In this study, we evaluated the feasibility of attenuating hepatic fibrosis by vaccination against TGF-β1 with TGF-β1 kinoids. Two TGF-β1 kinoid vaccines were prepared by cross-linking TGF-β1-derived polypeptides (TGF-β1 –[41-65] and TGF-β1 –[83-112]) to keyhole limpet hemocyanin (KLH). Immunization with the 25 30 two TGF-β1 kinoids efficiently elicited the production of high-levels of TGF-β1-specific antibodies against in BALB/c mice as tested by enzyme-linked immunosorbent assay (ELISA) and Western blotting. The antisera neutralized TGF- β1-induced growth-inhibition on mink lung epithelial cells (Mv1Lu) and attenuated TGF-β1-induced Smad2/3 phosphorylation, α-SMA, collagen type 1 alpha 2 (COL1A2), plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression in the rat hepatic stellate cell (HSC) line, HSC-T6. Vaccination against TGF-β1 with the kinoids significantly suppressed CCl4-induced collagen deposition and the expression of α- SMA and desmin, attenuated hepatocyte apoptosis and accelerated hepatocyte proliferation

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档